Axonics Modulation Technologies Quarterly Balance Sheets Chart
Quarterly
|
Annual
Axonics Modulation Technologies Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||
| current assets | |||||||||||||||||||||||||
| cash and cash equivalents | 239,452,000 | 168,619,000 | 232,645,000 | 104,811,000 | 147,323,000 | 145,343,000 | 240,105,000 | 238,846,000 | 241,331,000 | 203,236,000 | 213,180,000 | 220,878,000 | 228,797,000 | 231,140,000 | 130,962,000 | 241,181,000 | 269,280,000 | 287,679,000 | 159,820,000 | 171,082,000 | 76,231,000 | 82,680,000 | 89,334,000 | 98,306,000 | 20,148,000 |
| short-term investments | 105,773,000 | 174,792,000 | 100,161,000 | 240,149,000 | 197,393,000 | 186,173,000 | 116,957,000 | 118,365,000 | 108,682,000 | 9,998,000 | 12,592,000 | 25,311,000 | 43,001,000 | 54,819,000 | 59,218,000 | 11,069,000 | |||||||||
| accounts receivable | 62,644,000 | 57,221,000 | 50,529,000 | 57,243,000 | 48,944,000 | 47,436,000 | 40,200,000 | 44,817,000 | 36,960,000 | 36,115,000 | 27,425,000 | 29,044,000 | 26,641,000 | 25,646,000 | 21,509,000 | 18,270,000 | 17,650,000 | 14,115,000 | 20,770,000 | 7,879,000 | 954,000 | 1,286,000 | 804,000 | 427,000 | 219,000 |
| inventory | 113,861,000 | 105,428,000 | 93,187,000 | 79,940,000 | 74,909,000 | 70,083,000 | 66,067,000 | 55,765,000 | 57,827,000 | 58,412,000 | 61,876,000 | 64,946,000 | 70,358,000 | 70,391,000 | 71,243,000 | 63,060,000 | 44,308,000 | 30,138,000 | 19,230,000 | 15,659,000 | 12,703,000 | 7,975,000 | 5,064,000 | 3,673,000 | 2,148,000 |
| prepaid expenses and other current assets | 4,184,000 | 6,003,000 | 5,508,000 | 9,279,000 | 6,816,000 | 6,361,000 | 6,342,000 | 7,282,000 | 4,561,000 | 5,366,000 | 4,952,000 | 6,449,000 | 4,433,000 | 5,006,000 | 4,658,000 | 5,435,000 | 3,220,000 | 3,573,000 | 4,245,000 | 4,468,000 | 2,625,000 | 3,074,000 | 2,778,000 | 3,716,000 | 1,751,000 |
| total current assets | 525,914,000 | 512,063,000 | 482,030,000 | 491,422,000 | 475,385,000 | 455,396,000 | 469,671,000 | 465,075,000 | 449,361,000 | 313,127,000 | 307,433,000 | 321,317,000 | 330,229,000 | 332,183,000 | 228,372,000 | 327,946,000 | 334,458,000 | 335,505,000 | 204,065,000 | 211,680,000 | 117,824,000 | 138,016,000 | 152,799,000 | 165,340,000 | 35,335,000 |
| restricted cash | 22,082,000 | 18,629,000 | 15,826,000 | 12,714,000 | |||||||||||||||||||||
| property and equipment | 20,698,000 | 18,382,000 | 17,037,000 | 10,760,000 | 6,556,000 | 6,349,000 | 7,017,000 | 6,798,000 | 7,103,000 | 7,228,000 | 6,907,000 | 6,915,000 | 6,168,000 | 5,958,000 | 6,048,000 | 6,328,000 | 5,792,000 | 5,562,000 | 5,406,000 | 3,047,000 | 2,952,000 | 3,000,000 | 2,887,000 | 2,784,000 | 2,817,000 |
| intangible assets | 78,454,000 | 76,333,000 | 78,422,000 | 81,375,000 | 80,274,000 | 85,543,000 | 85,888,000 | 86,253,000 | 81,787,000 | 91,627,000 | 101,179,000 | 106,469,000 | 108,302,000 | 113,416,000 | 115,023,000 | ||||||||||
| other assets | 22,478,000 | 23,183,000 | 23,703,000 | 24,235,000 | 3,245,000 | 2,817,000 | 6,534,000 | 6,813,000 | 7,085,000 | 7,254,000 | 7,494,000 | 7,734,000 | 7,041,000 | 7,324,000 | 8,145,000 | 7,736,000 | 7,196,000 | 7,415,000 | 7,626,000 | 4,784,000 | 4,928,000 | 5,068,000 | 3,344,000 | 3,356,000 | 3,712,000 |
| goodwill | 104,545,000 | 98,747,000 | 98,543,000 | 99,417,000 | 95,287,000 | 98,880,000 | 96,581,000 | 94,414,000 | 86,942,000 | 94,852,000 | 102,558,000 | 105,510,000 | 109,565,000 | 106,631,000 | 87,382,000 | ||||||||||
| total assets | 774,171,000 | 747,337,000 | 715,561,000 | 719,923,000 | 660,747,000 | 648,985,000 | 665,691,000 | 659,353,000 | 632,278,000 | 514,088,000 | 525,571,000 | 547,945,000 | 561,305,000 | 565,512,000 | 444,970,000 | 342,206,000 | 347,671,000 | 348,736,000 | 217,379,000 | 219,822,000 | 126,044,000 | 146,452,000 | 159,427,000 | 171,906,000 | 42,319,000 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||
| current liabilities | |||||||||||||||||||||||||
| accounts payable | 20,109,000 | 19,316,000 | 15,770,000 | 18,452,000 | 14,666,000 | 12,185,000 | 14,737,000 | 9,070,000 | 9,972,000 | 10,207,000 | 10,390,000 | 7,654,000 | 10,512,000 | 9,447,000 | 11,446,000 | 10,660,000 | 9,415,000 | 10,728,000 | 7,440,000 | 5,882,000 | 4,232,000 | 3,185,000 | 2,102,000 | 3,436,000 | 1,983,000 |
| accrued liabilities | 5,701,000 | 11,042,000 | 14,752,000 | 10,527,000 | 5,962,000 | 5,571,000 | 6,640,000 | 6,520,000 | 7,106,000 | 7,301,000 | 6,246,000 | 5,435,000 | 6,424,000 | 6,305,000 | 5,868,000 | 6,684,000 | 5,977,000 | 3,961,000 | 3,110,000 | 2,174,000 | 4,304,000 | 3,630,000 | 2,364,000 | 1,683,000 | 2,713,000 |
| accrued compensation and benefits | 35,998,000 | 24,793,000 | 16,409,000 | 15,060,000 | 12,994,000 | 12,559,000 | 8,836,000 | 15,495,000 | 11,742,000 | 10,922,000 | 7,480,000 | 12,413,000 | 9,305,000 | 7,198,000 | 5,348,000 | 5,948,000 | 7,516,000 | 5,289,000 | 3,503,000 | 3,375,000 | |||||
| operating lease liabilities, current portion | 2,611,000 | 2,022,000 | 1,456,000 | 1,777,000 | 1,971,000 | ||||||||||||||||||||
| total current liabilities | 64,419,000 | 57,173,000 | 48,387,000 | 45,816,000 | 35,593,000 | 32,084,000 | 66,170,000 | 65,247,000 | 60,843,000 | 29,859,000 | 25,519,000 | 26,868,000 | 27,751,000 | 24,387,000 | 24,046,000 | 45,682,000 | 38,816,000 | 30,829,000 | 19,847,000 | 12,033,000 | 15,543,000 | 11,300,000 | 6,694,000 | 5,887,000 | 5,496,000 |
| operating lease liabilities, net of current portion | 29,900,000 | 30,431,000 | 30,154,000 | 25,840,000 | 876,000 | ||||||||||||||||||||
| deferred tax liabilities | 15,363,000 | 16,417,000 | 9,921,000 | 10,703,000 | 13,658,000 | 15,173,000 | 15,737,000 | 16,412,000 | 13,957,000 | 15,782,000 | 17,564,000 | 19,217,000 | 26,432,000 | 20,626,000 | |||||||||||
| total liabilities | 109,682,000 | 104,021,000 | 88,462,000 | 82,359,000 | 50,127,000 | 48,456,000 | 89,085,000 | 89,214,000 | 82,760,000 | 76,362,000 | 62,139,000 | 65,507,000 | 71,215,000 | 61,247,000 | 114,816,000 | 54,836,000 | 53,773,000 | 50,840,000 | 44,903,000 | 36,819,000 | 33,856,000 | 32,039,000 | 28,093,000 | 28,631,000 | 18,005,000 |
| commitments and contingencies | |||||||||||||||||||||||||
| stockholders’ equity | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at september 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||
| common stock | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 4,000 | 4,000 | 4,000 | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | |
| additional paid-in capital | 1,063,185,000 | 1,052,429,000 | 1,043,577,000 | 1,033,778,000 | 1,022,052,000 | 1,009,704,000 | 982,189,000 | 969,545,000 | 960,627,000 | 820,526,000 | 812,141,000 | 803,559,000 | 796,397,000 | 788,184,000 | 589,785,000 | 522,296,000 | 517,659,000 | 512,588,000 | 367,278,000 | 363,012,000 | 249,599,000 | 246,706,000 | 244,523,000 | 243,337,000 | 3,336,000 |
| accumulated deficit | -392,586,000 | -392,565,000 | -399,464,000 | -380,352,000 | -386,926,000 | -390,854,000 | -383,512,000 | -374,264,000 | -374,929,000 | -358,677,000 | -337,234,000 | -314,566,000 | -299,400,000 | -282,150,000 | -257,002,000 | -234,499,000 | -223,151,000 | -213,983,000 | -194,200,000 | -179,584,000 | -156,833,000 | -131,827,000 | -112,766,000 | -99,649,000 | -89,984,000 |
| accumulated other comprehensive loss | -6,115,000 | -16,553,000 | -17,019,000 | -15,867,000 | -24,511,000 | -18,326,000 | -22,076,000 | -25,147,000 | -36,185,000 | -24,128,000 | -11,480,000 | -6,560,000 | -6,912,000 | -1,774,000 | -2,633,000 | -431,000 | -614,000 | -713,000 | -605,000 | -428,000 | -581,000 | -469,000 | -426,000 | -416,000 | -406,000 |
| total stockholders’ equity | 664,489,000 | 643,316,000 | 627,099,000 | 637,564,000 | 610,620,000 | 600,529,000 | 576,606,000 | 570,139,000 | 549,518,000 | 437,726,000 | 463,432,000 | 482,438,000 | 490,090,000 | 504,265,000 | 330,154,000 | 287,370,000 | 293,898,000 | 297,896,000 | 172,476,000 | 183,003,000 | 92,188,000 | 114,413,000 | 131,334,000 | 143,275,000 | |
| total liabilities and stockholders’ equity | 774,171,000 | 747,337,000 | 715,561,000 | 719,923,000 | 660,747,000 | 648,985,000 | 665,691,000 | 659,353,000 | 632,278,000 | 514,088,000 | 525,571,000 | 547,945,000 | 561,305,000 | 565,512,000 | 444,970,000 | 342,206,000 | 347,671,000 | 348,736,000 | 217,379,000 | 219,822,000 | 126,044,000 | 146,452,000 | 159,427,000 | ||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at june 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at march 31, 2024 and december 31, 2023 | |||||||||||||||||||||||||
| other current liabilities | 34,400,000 | 32,600,000 | 30,500,000 | ||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at december 31, 2023 and 2022 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at september 30, 2023 and december 31, 2022 | |||||||||||||||||||||||||
| operating lease liability, current portion | 1,769,000 | 1,557,000 | 1,562,000 | 1,523,000 | 1,429,000 | 1,403,000 | 1,366,000 | 1,401,000 | 1,407,000 | 1,362,000 | 1,280,000 | 908,000 | 851,000 | 794,000 | 602,000 | ||||||||||
| operating lease liability, net of current portion | 1,199,000 | 7,178,000 | 7,555,000 | 7,960,000 | 8,321,000 | 8,686,000 | 9,052,000 | 8,152,000 | 8,481,000 | 8,849,000 | 9,154,000 | 9,027,000 | 9,261,000 | 9,485,000 | 4,450,000 | ||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at june 30, 2023 and december 31, 2022 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at march 31, 2023 and december 31, 2022 | |||||||||||||||||||||||||
| other long-term liabilities | 22,400,000 | 10,370,000 | 10,370,000 | 8,880,000 | 7,664,000 | 6,750,000 | |||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at december 31, 2022 and 2021 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at september 30, 2022 and december 31, 2021 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at june 30, 2022 and december 31, 2021 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at march 31, 2022 and december 31, 2021 | |||||||||||||||||||||||||
| debt, net of unamortized debt issuance costs, current portion | 109,000 | 30,000 | 22,000 | 21,110,000 | 6,382,000 | 3,897,000 | 1,705,000 | ||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at december 31, 2021 and 2020 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at september 30, 2021 and december 31, 2020 | |||||||||||||||||||||||||
| debt, net of unamortized debt issuance costs, net of current portion | 89,000 | 75,171,000 | 5,930,000 | 10,750,000 | 15,571,000 | 13,740,000 | 16,000,000 | 17,923,000 | |||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at june 30, 2021 and december 31, 2020 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at march 31, 2021 and december 31, 2020 | |||||||||||||||||||||||||
| intangible asset | 196,000 | 225,000 | 254,000 | 282,000 | 311,000 | 340,000 | 368,000 | 397,000 | 426,000 | 455,000 | |||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at december 31, 2020 and 2019 | |||||||||||||||||||||||||
| debt, current portion | 15,000,000 | 10,000,000 | 5,000,000 | ||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at september 30, 2020 and december 31, 2019 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at june 30, 2020 and december 31, 2019 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at march 31, 2020 and december 31, 2019 | |||||||||||||||||||||||||
| debt, net of unamortized debt issuance costs | 20,336,000 | 19,463,000 | 9,056,000 | ||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at december 31, 2019 and 2018 | |||||||||||||||||||||||||
| lease liability, current portion | 625,000 | 588,000 | 523,000 | 768,000 | 800,000 | ||||||||||||||||||||
| lease liability, net of current portion | 4,573,000 | 4,739,000 | 3,476,000 | 3,281,000 | 3,453,000 | ||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at september 30, 2019 and december 31, 2018 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at june 30, 2019 and december 31, 2018 | |||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at march 31, 2019 and december 31, 2018 | |||||||||||||||||||||||||
| liabilities, mezzanine equity and stockholders’ equity | |||||||||||||||||||||||||
| mezzanine equity | |||||||||||||||||||||||||
| convertible preferred stock | |||||||||||||||||||||||||
| series a convertible preferred stock, par value 0.0001, no shares authorized, issued, and outstanding at december 31, 2018; 1,030,000 shares authorized, 719,500 shares issued and outstanding at december 31, 2017; aggregate liquidation preference of 0 and 15,829 at december 31, 2018 and 2017, respectively | |||||||||||||||||||||||||
| series b-1 convertible preferred stock, par value 0.0001, no shares authorized, issued, and outstanding at december 31, 2018; 2,529,862 shares authorized, 1,925,302 shares issued and outstanding at december 31, 2017; aggregate liquidation preference of 0 and 15,248 at december 31, 2018 and 2017, respectively | |||||||||||||||||||||||||
| series b-2 convertible preferred stock, par value 0.0001, no shares authorized, issued, and outstanding at december 31, 2018; 2,537,231 shares authorized, 2,213,794 shares issued and outstanding at december 31, 2017; aggregate liquidation preference of 0 and 19,481 at december 31, 2018 and 2017, respectively | |||||||||||||||||||||||||
| series c convertible preferred stock, par value 0.0001, no shares authorized, issued, and outstanding at december 31, 2018; 3,888,889 shares authorized, 1,898,213 shares issued and outstanding at december 31, 2017; aggregate liquidation preference of 0 and 17,084 at december 31, 2018 and 2017, respectively | |||||||||||||||||||||||||
| noncontrolling interest in axonics europe, s.a.s. | 31,066,000 | ||||||||||||||||||||||||
| preferred stock, par value 0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at december 31, 2018; no shares authorized, issued, and outstanding at december 31, 2017 | |||||||||||||||||||||||||
| stock subscriptions receivable | -1,824,000 | ||||||||||||||||||||||||
| total liabilities, mezzanine equity and stockholders’ equity | 171,906,000 | ||||||||||||||||||||||||
| liabilities, mezzanine equity and stockholders’ deficit | |||||||||||||||||||||||||
| series a convertible preferred stock, par value 0.0001, 1,030,000 shares authorized, 719,500 shares issued and outstanding at september 30, 2018 and december 31, 2017; aggregate liquidation preference of 15,829 at september 30, 2018 and december 31, 2017 | 14,021,000 | ||||||||||||||||||||||||
| series b-1 convertible preferred stock, par value 0.0001, 2,529,862 shares authorized, 1,925,302 shares issued and outstanding at september 30, 2018 and december 31, 2017; aggregate liquidation preference of 15,248 at september 30, 2018 and december 31, 2017 | 13,757,000 | ||||||||||||||||||||||||
| series b-2 convertible preferred stock, par value 0.0001, 2,537,231 shares authorized, 2,213,794 shares issued and outstanding at september 30, 2018 and december 31, 2017; aggregate liquidation preference of 19,481 at september 30, 2018 and december 31, 2017 | 17,572,000 | ||||||||||||||||||||||||
| series c convertible preferred stock, par value 0.0001, 6,188,888 and 3,888,889 shares authorized at september 30, 2018 and december 31, 2017, respectively; 4,131,546 and 1,898,213 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively; aggregate liquidation preference of 37,184 and 17,084 at september 30, 2018 and december 31, 2017, respectively | 36,776,000 | ||||||||||||||||||||||||
| stockholders’ deficit | |||||||||||||||||||||||||
| total stockholders’ deficit | -88,878,000 | ||||||||||||||||||||||||
| total liabilities, mezzanine equity and stockholders’ deficit | 42,319,000 |
We provide you with 20 years of balance sheets for Axonics Modulation Technologies stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Axonics Modulation Technologies. Explore the full financial landscape of Axonics Modulation Technologies stock with our expertly curated balance sheets.
The information provided in this report about Axonics Modulation Technologies stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.